Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Sladko K, Roubicek K, Pfister T, Rettenbacher M, Volk HD, Wagner F, Müller P, Jennings GT, Bachmann MF. Ambühl PM, et al. Among authors: pfister t. J Hypertens. 2007 Jan;25(1):63-72. doi: 10.1097/HJH.0b013e32800ff5d6. J Hypertens. 2007. PMID: 17143175 Clinical Trial.
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G. Sitbon O, et al. Among authors: pfister t. Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3. Am Heart J. 2014. PMID: 24439982 Free article. Clinical Trial.
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
Frost A, Janmohamed M, Fritz JS, McConnell JW, Poch D, Fortin TA, Miller CE, Chin KM, Fisher M, Eggert M, McEvoy C, Benza RL, Farber HW, Kim NH, Pfister T, Shiraga Y, McLaughlin V. Frost A, et al. Among authors: pfister t. J Heart Lung Transplant. 2019 Jan;38(1):43-50. doi: 10.1016/j.healun.2018.09.003. Epub 2018 Sep 12. J Heart Lung Transplant. 2019. PMID: 30391194 Free article. Clinical Trial.
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.
Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanç M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V; CAP Study Investigators. Cutolo M, et al. Among authors: pfister t. Arthritis Rheumatol. 2016 Oct;68(10):2527-39. doi: 10.1002/art.39718. Arthritis Rheumatol. 2016. PMID: 27111549 Free PMC article.
Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach.
Sehner C, Bernier T, Blum K, Clemann N, Glogovac M, Hawkins WA, Kohan M, Linker F, Lovsin-Barle E, Osadolor O, Pfister T, Schulze E, Schwind M, Tuschl G, Wiesner L. Sehner C, et al. Among authors: pfister t. Regul Toxicol Pharmacol. 2024 Jun;150:105649. doi: 10.1016/j.yrtph.2024.105649. Epub 2024 May 21. Regul Toxicol Pharmacol. 2024. PMID: 38782234
120 results